Resources from the same session
Oesophageal squamous cell carcinoma: Treatment landscape, clinical guidelines and immunotherapy
Presenter: Filippo Pietrantonio
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast
A focus on recent data for PD-1 inhibitors in first- and second-line treatment of oesophageal squamous cell carcinoma
Presenter: Jean-Philippe Metges
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast
New era for pathologists: PD-L1 expression in upper GI cancers
Presenter: Matteo Fassan
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast
Management and individualised approaches for patients with gastric and gastro-oesophageal junction adenocarcinoma
Presenter: Sylvie Lorenzen
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast
Novel immunological combinations in first-line treatment of gastric and gastro-oesophageal junction adenocarcinoma
Presenter: Maria Alsina Maqueda
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast
Conclusions and Q&A
Presenter: Maria Alsina Maqueda
Session: BeiGene - Advances in upper GI immunotherapy: What’s new on the horizon?
Resources:
Webcast